| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Gene
Endocrine Unit (A.P., B.C., P.L., F.C., L.B., M.S.) and Medical Genetics Unit (S.B.-P.), Department of Clinical Physiopathology, University of Florence, 50139 Florence, Italy; and Institute of Endocrine Sciences, Ospedale Maggiore, University of Milan (S.C., E.B., A.S.), 20122 Milan, Italy
Address all correspondence and requests for reprints to: Alessandro Peri, M.D., Ph.D., Endocrine Unit, Department of Clinical Physiopathology, University of Florence, Viale Pieraccini, 6, 50139 Florence, Italy. E-mail: a.peri{at}dfc.unifi.it
In about 3040% of GH-secreting adenomas, gain-of-function mutations
of the Gs
gene, which convert this gene into an
oncogene termed gsp, occur. Gs
mutations have been related to pituitary tumorigenesis. We focused on 2
nuclear transcription factors that are final targets of the
cAMP-dependent pathway and are positively regulated by cAMP signaling,
i.e. the cAMP-responsive element binding protein (CREB)
and the inducible cAMP early repressor (ICER), that derives from
alternative splicing of cAMP-responsive element modulator gene. We
examined 21 GH-secreting adenomas, 8 with
(gsp+) and 13 without
(gsp-) a mutated
Gs
. Analysis of CREB and ICER I/II messenger RNA
revealed that the levels of both transcripts were higher in
gsp+ than in
gsp- tumors
(CREB/glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mean optical
density ± SE, 2.34 ± 0.36 in
gsp+ vs. 0.99 ± 0.22 in
gsp-, P = 0.003;
ICER I/GAPDH, 0.53 ± 0.15 in gsp+
vs. 0.14 ± 0.07 in
gsp-, P = 0.01;
ICER II/GAPDH, 1.5 ± 0.21 in gsp+
vs. 0.83 ± 0.13 in
gsp-, P = 0.01),
although a few cases in both groups did not display this pattern of
expression. Moreover, no positive correlation between the levels of
CREB and ICER transcripts was observed, suggesting the possible
presence of alterations in the mechanisms by which cAMP signaling
directs the expression of CREB and/or ICER genes. Our results indicate
a complex pattern of expression of nuclear transcription factors that
mediate cAMP action in both gsp+ and
gsp- tumors, suggesting that, beside
Gs
gene mutations, different and partially unknown
molecular events may contribute to the pathogenesis of these tumors.
This article has been cited by other articles:
![]() |
D. Romano, K. Magalon, M. Pertuit, R. Rasolonjanahary, A. Barlier, A. Enjalbert, and C. Gerard Conditional Overexpression of the Wild-Type Gs{alpha} as the gsp Oncogene Initiates Chronic Extracellularly Regulated Kinase 1/2 Activation and Hormone Hypersecretion in Pituitary Cell Lines Endocrinology, June 1, 2007; 148(6): 2973 - 2983. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Luciani, S. Gelmini, E. Ferrante, A. Lania, S. Benvenuti, S. Baglioni, G. Mantovani, I. Cellai, F. Ammannati, A. Spada, et al. Expression of the Antiapoptotic Gene Seladin-1 and Octreotide-Induced Apoptosis in Growth Hormone-Secreting and Nonfunctioning Pituitary Adenomas J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6156 - 6161. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lania, G. Mantovani, and A. Spada Genetics of Pituitary Tumors: Focus on G-Protein Mutations Experimental Biology and Medicine, October 1, 2003; 228(9): 1004 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Mead, T. R. Hughes, S. A. Irvine, N. N. Singh, and D. P. Ramji Interferon-gamma Stimulates the Expression of the Inducible cAMP Early Repressor in Macrophages through the Activation of Casein Kinase 2. A POTENTIALLY NOVEL PATHWAY FOR INTERFERON-gamma -MEDIATED INHIBITION OF GENE TRANSCRIPTION J. Biol. Chem., May 9, 2003; 278(20): 17741 - 17751. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. ROSENBERG, L. GROUSSIN, E. JULLIAN, K. PERLEMOINE, X. BERTAGNA, and J. BERTHERAT Role of the PKA-Regulated Transcription Factor CREB in Development and Tumorigenesis of Endocrine Tissues Ann. N.Y. Acad. Sci., June 1, 2002; 968(1): 65 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Peri, P. Luciani, B. Conforti, S. Baglioni-Peri, F. Cioppi, C. Crescioli, P. Ferruzzi, S. Gelmini, G. Arnaldi, G. Nesi, et al. Variable Expression of the Transcription Factors cAMP Response Element-Binding Protein and Inducible cAMP Early Repressor in the Normal Adrenal Cortex and in Adrenocortical Adenomas and Carcinomas J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5443 - 5449. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |